Why Galapagos Trounced the Market Today
A high-profile healthcare industry executive has been tapped as the company's new CEO.
Galapagos(GLPG)
Nasdaq Global Select
GLPG
$55.28
$0.02
0.0%
Price as of May 25, 2022, 3:12 p.m. ET
View Interactive GLPG Charts
GALAPAGOS NV SPON ADR REPR 1 ORD SHS
Interactive Chart
Compare GLPG Stock to Peers
| Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
|---|---|---|---|---|
|
GLPG
Galapagos
|
$54.83 | $4B | -24.3% | -34.2% |
|
BHC |
$9.61 | $3B | -70.4% | -27.4% |
|
CRSP |
$54.71 | $4B | -54.7% | 240.6% |
|
CRLBF |
$3.90 | $2B | -65.0% | |
|
PACB |
$5.43 | $1B | -79.1% | 43.7% |
News & Analysis: Galapagos
The Fool has written over 100 articles on Galapagos.
Galapagos NV (GLPG) Q3 2021 Earnings Call Transcript
GLPG earnings call for the period ending September 30, 2021.
Galapagos NV (GLPG) Q2 2021 Earnings Call Transcript
GLPG earnings call for the period ending June 30, 2021.
Here's Why Galapagos Stock Is Falling Today
The company's new salt-inducable kinase inhibitor program is getting off to a rocky start.
Galapagos NV (GLPG) Q1 2021 Earnings Call Transcript
GLPG earnings call for the period ending March 31, 2021.
Is Galapagos Stock a Bad-News Buy Right Now?
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices.
Galapagos NV (GLPG) Q4 2020 Earnings Call Transcript
GLPG earnings call for the period ending December 31, 2020.
Why Galapagos Stock Is Crashing Today
The FDA dealt the biotech and its big partner a huge setback.
Galapagos NV (GLPG) Q2 2020 Earnings Call Transcript
GLPG earnings call for the period ending June 30, 2020.
3 Biotech Stocks With Big Incoming Catalysts
Binary events could send shares of these stocks screaming higher, or lower, soon.
